University of Glasgow
Circulating microRNAs as diagnostic biomarkers in canine idiopathic and drug-resistant epilepsy
Abstract
dc:description.abstractBackground: Reliable and easily measurable biomarkers are needed to identify dogs with drug-resistant and idiopathic epilepsy. Circulating miRNAs may serve as both therapeutic targets and diagnostic or prognostic biomarkers for canine idiopathic epilepsy. Hypothesis/Objectives: To determine whether specific circulating miRNAs are differentially expressed in dogs with idiopathic epilepsy and to evaluate their ability to distinguish drug-resistant cases from responders. Methods: Circulating miRNA profiles were assessed in plasma samples from dogs with idiopathic epilepsy (drug-naïve, treatment-responsive, and drug-resistant) and healthy controls using expression profiling techniques. Candidate miRNAs identified from the analysis were subsequently validated using quantitative real-time PCR (qRT-PCR). Results: Sequencing of circulating serum miRNAs identified clear expression differences between clinical groups. When comparing healthy controls with drug‑naïve epileptic dogs, 45 miRNAs were significantly differentially expressed (p < 0.05), including miR‑381, miR‑214, and miR‑224, which showed robust upregulation (fold change > 1.5; p < 0.01). In the comparison between drug‑resistant and treatment‑responsive epileptic dogs, six miRNAs were significantly altered, with miR‑223 demonstrating reduced expression (p < 0.05) and miR‑210 increased expression (p < 0.05) in resistant animals. RT‑qPCR validation confirmed these sequencing‑based findings: miR‑214 was consistently upregulated in epileptic dogs relative to healthy controls (p < 0.05), supporting its diagnostic potential. miR‑223 expression was significantly lower in drug‑resistant dogs compared with responders (p < 0.05), while miR‑210 was markedly elevated in resistant animals (p < 0.05). Together, these results highlight a subset of circulating miRNAs--particularly miR‑214, miR‑223, and miR‑210--that show reproducible, clinically relevant expression changes and may serve as biomarkers for both epilepsy diagnosis and treatment stratification in dogs. Conclusions and Clinical Importance: Differentially expressed miRNAs were identified, and their specificity, sensitivity, and expression levels were used to identify the most promising biomarkers. The results of this study indicate a potential role of miRNAs in the underlying molecular mechanisms of idiopathic and drug-resistant epilepsy in dogs, highlighting their use as potential biomarkers and establishing the basis for further studies.
Degree
thesis:*- Level dc:type.qualificationlevel
- MVM(R)
- Grantor dc:publisher.institution
- University of Glasgow
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Pasierbinska, Maria
Rights
- Language dc:language
- en
Identifiers
dc:identifier.*- DOI dc:identifier.doi
- https://doi.org/10.5525/gla.thesis.86358